• Develop a model to estimate and visualise clinical and economic benefits of a of dialysis program in the UK. • Present economic model as interactive web-based app and develop dedicated data visualisations to effectively communicate complex, multilayered health data and inform regional healthcare budgeting and decision making regarding public health value of a dialyses program for patients with chronic kidney disease
• Facilitate understanding of health economics models by provision of innovative web/ipad based communications tool. Improve communication of the economic value story with HTML interface
METHOD

RESULTS CONCLUSIONS
• Economic model estimated that dialyses is a cost saving programme
• An economic model powered with web capabilities and dedicated data visualisation libraries is a more effective tool to convey detailed economic data
• Models deployed as web apps remove data presentation limitations of conventional modelling packages like MS Excel and utilise advantages of dedicated data visualisation libraries and web environment to more effectively present and communicate results of budget impact models
• eModels -interactive health economics models delivered as iPad/Web apps -can convey the economic value story in a format tailored to the specific needs of the particular audience.
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• The model utilises UK Hospital Episode Statistics (HES) as a primary data source.
• 
Visual communication Functional capabilities
Better content perception due to information architecture design and data visualization best practices [1] Interactive data visualization enables user's interactions with data -the ability to drill down and explore relations between various data points Interactive storyboard approach, by walking users through all the model stages gradually, enables to tailor the value proposition depending on particular audiences, as well as improves overall user interaction and accessibility. Model interface screens. Estimates of economic impact and direct medical cost savings.
• Direct medical cost savings following an introduction of a dialysis therapy are estimated to be GBP 4,475 per patient
• Cost savings in outpatient and inpatient settings were GBP 320 and GBP 2,458 respectively
• Sensitivity analyses indicated that efficacy and direct cost parameters had the strongest magnitude of impact on model base case results
• Reductions in the use of concomitant medications and lower disease control cost led to cost savings
• Favourable bioavailability of a dialyses program allowed more patients to be treated using oral agents and resulted in cost savings for the healthcare system
• Interactive chart in the Results section allows to change input parameters on the go and observe the corresponding outputs changes in real time. Special price difference slider control allows to quickly switch between multipliers
• The model dynamically generates *.pdf report with custom input data entered by the user and provides an opportunity to download it and/or send via e-mail.
